Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study

By  

Journal Of Veterinary Internal Medicine, Vol. 27, Iss. 6, 2013-11 ,pp. : 1441-1451

John Wiley & Sons Inc

Access to resources Recommend Favorite

Diagnostic Value of Selected Echocardiographic Variables to Identify Pulmonary Hypertension in Dogs with Myxomatous Mitral Valve Disease

By  

Journal Of Veterinary Internal Medicine, Vol. 29, Iss. 6, 2015-11 ,pp. : 1510-1517

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short‐Term Hemodynamic and Neuroendocrine Effects of Pimobendan and Benazapril in Dogs with Myxomatous Mitral Valve Disease and Congestive Heart Failure

By  

Journal Of Veterinary Internal Medicine, Vol. 27, Iss. 6, 2013-11 ,pp. : 1452-1462

John Wiley & Sons Inc

Access to resources Recommend Favorite

Echocardiographic Estimates of Right Ventricular Systolic Function in Dogs with Myxomatous Mitral Valve Disease

By  

Journal Of Veterinary Internal Medicine, Vol. 32, Iss. 1, 2018-01 ,pp. : 64-71

John Wiley & Sons Inc

Access to resources Recommend Favorite

Short-term effect of granulocyte colony-stimulating factor in dogs with severe myxomatous mitral valve disease

By Kang Min-Hee   Park Hee-Myung  

Veterinary Quarterly, Vol. 34, Iss. 2, 2014-04 ,pp. : 60-66

Taylor & Francis Ltd

Access to resources Recommend Favorite